Sgarbossa E B, Pinski S L, Maloney J D
Department of Cardiology, Cleveland Clinic Foundation, OH 44195.
Ann Intern Med. 1993 Sep 1;119(5):359-65. doi: 10.7326/0003-4819-119-5-199309010-00002.
To determine whether the atrial-based pacing modalities ("physiologic pacing") improve survival when compared with single-chamber ventricular pacing in patients with the sick sinus syndrome.
Retrospective, nonrandomized study.
A tertiary care teaching hospital.
A total of 507 patients with a mean age of 66 years who received an initial pacemaker for the sick sinus syndrome between January 1980 and December 1989. Pacing modes were ventricular (22%), atrial (4%), and dual-chamber (74%).
Total and cardiovascular mortality rates. Mean follow-up was 66 months.
Independent predictors of total mortality by the Cox proportional hazards model were 1) New York Heart Association functional class (hazard ratio = 1.67/class; 95% Cl, 1.31 to 2.11); 2) age (hazard ratio = 1.62/12-year increment; Cl, 1.28 to 2.05); 3) peripheral vascular disease (hazard ratio = 2.21; Cl, 1.42 to 3.42); 4) bundle branch block (hazard ratio = 2.04; Cl, 1.33 to 3.13); 5) coronary artery disease (hazard ratio = 1.66; Cl, 1.15 to 2.39); and 6) valvular heart disease (hazard ratio = 1.71; Cl, 1.08 to 2.69). The same variables were independent predictors of cardiovascular mortality, with cerebrovascular disease reaching borderline statistical significance (hazard ratio = 1.69; Cl, 1.00 to 2.86). Using univariate analysis, single-chamber ventricular pacing had more than 40% increased risk for both total and cardiovascular death, but the difference was of borderline statistical significance (total mortality: P = 0.053; hazard ratio = 1.43; Cl, 0.99 to 2.07; cardiovascular mortality: P = 0.15; hazard ratio = 1.41; Cl = 0.87 to 2.29).
Because the role of the ventricular pacing mode as a long-term predictor of total and cardiovascular mortality remains inconclusive, a large, randomized study is necessary to confirm whether physiologic pacing provides a substantial reduction in mortality when compared with ventricular pacing.
确定与病态窦房结综合征患者的单腔心室起搏相比,心房起搏模式(“生理性起搏”)是否能提高生存率。
回顾性、非随机研究。
一家三级护理教学医院。
共有507例平均年龄66岁的患者,于1980年1月至1989年12月期间因病态窦房结综合征首次接受起搏器治疗。起搏模式为心室起搏(22%)、心房起搏(4%)和双腔起搏(74%)。
总死亡率和心血管死亡率。平均随访时间为66个月。
根据Cox比例风险模型,总死亡率的独立预测因素为:1)纽约心脏协会心功能分级(风险比=1.67/级;95%可信区间,1.31至2.11);2)年龄(风险比=1.62/每增加12岁;可信区间,1.28至2.05);3)外周血管疾病(风险比=2.21;可信区间,1.42至3.42);4)束支传导阻滞(风险比=2.04;可信区间,1.33至3.13);5)冠状动脉疾病(风险比=1.66;可信区间,1.15至2.39);6)瓣膜性心脏病(风险比=1.71;可信区间,1.08至2.69)。相同变量是心血管死亡率的独立预测因素,脑血管疾病达到边缘统计学显著性(风险比=1.69;可信区间,1.00至2.86)。采用单因素分析,单腔心室起搏的总死亡风险和心血管死亡风险均增加40%以上,但差异具有边缘统计学显著性(总死亡率:P=0.053;风险比=1.43;可信区间,0.99至2.07;心血管死亡率:P=0.15;风险比=1.41;可信区间=0.87至2.29)。
由于心室起搏模式作为总死亡率和心血管死亡率的长期预测因素的作用仍不明确,因此需要进行一项大型随机研究,以证实与心室起搏相比,生理性起搏是否能显著降低死亡率。